8-K: Catheter Precision Secures $100,000 Loan from CEO Amidst Ongoing Funding Efforts

Catheter Precision, Inc. received a $100,000 short-term loan from its CEO, David A. Jenkins, with an 8% interest rate, due August 30, 2024.

Summary

• Catheter Precision, Inc. has obtained a $100,000 loan from an entity controlled by its CEO, David A. Jenkins.
• The loan is structured as an 8% short-term promissory note, maturing on August 30, 2024.
• This loan is in addition to previous loans from Mr. Jenkins totaling $900,000 in May, June and July 2024.
• The note's repayment is expected to come from proceeds of a planned sale of securities.
• The note includes customary default clauses, such as failure to pay, breach of warranties, or insolvency events.
• Mr. Jenkins and his affiliates have significant holdings in the company, including over 10% of common stock, preferred stock convertible into over 800,000 shares, stock options, and royalty rights on LockeT device sales.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the loan provides necessary short-term funding, it also highlights the company's reliance on debt and the need for a successful capital raise.

Positives

• The company has secured additional short-term funding of $100,000.
• The CEO's willingness to provide further loans indicates confidence in the company's future.
• The loan is expected to be repaid from proceeds of a planned sale of securities, which could provide a clear path for repayment.

Negatives

• The company is relying on short-term loans from its CEO, suggesting potential cash flow issues.
• The 8% interest rate on the loan is relatively high, increasing the company's financial burden.
• The company's reliance on a single individual for funding could pose a risk if that individual's circumstances change.

Risks

• The company's ability to repay the loan depends on the successful sale of securities.
• Failure to secure sufficient funds from the sale of securities could lead to default on the loan.
• The company's financial health is heavily reliant on the CEO's continued support.
• The company is subject to standard default clauses, including insolvency, which could trigger immediate repayment of the loan.

Future Outlook

The company expects to repay the loan from the proceeds of a planned sale of securities pursuant to its registration statement on Form S-1.

Management Comments

• The company has not provided any direct quotes from management in this document.

Industry Context

This type of short-term loan from a CEO is not uncommon for small, developing companies that are seeking to bridge funding gaps while pursuing larger capital raises. It highlights the company's need for capital and the CEO's commitment to the company's operations.

Comparison to Industry Standards

• It is common for early-stage medical device companies to rely on bridge financing from founders and insiders.
• The 8% interest rate is relatively high, which is typical for short-term, high-risk loans.
• Comparable companies in the medical device sector often use a combination of equity and debt financing to fund operations and development.
• The reliance on a single individual for funding is a risk factor that is not uncommon in early-stage companies.

Related Party Transactions

• The loan from David A. Jenkins, the CEO, is a related party transaction.
• Mr. Jenkins and his affiliates have significant holdings in the company, including over 10% of common stock, preferred stock convertible into over 800,000 shares, stock options, and royalty rights on LockeT device sales.

Stakeholder Impact

• Shareholders may be concerned about the company's reliance on debt financing.
• Employees may be impacted by the company's financial situation.
• Creditors may be impacted by the company's debt obligations.
• Customers and suppliers may be impacted by the company's ability to continue operations.

Next Steps

• The company needs to successfully complete its planned sale of securities to repay the loan.
• The company needs to continue to manage its cash flow and operations.

Key Dates

Keywords

promissory note, short-term loan, related party transaction, funding, debt financing, securities, Catheter Precision, David A. Jenkins